These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7570747)

  • 21. Glucose affects the severity of hypoxic-ischemic brain injury in newborn pigs.
    LeBlanc MH; Huang M; Vig V; Patel D; Smith EE
    Stroke; 1993 Jul; 24(7):1055-62. PubMed ID: 8322380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain.
    Gilron I; Max MB; Lee G; Booher SL; Sang CN; Chappell AS; Dionne RA
    Clin Pharmacol Ther; 2000 Sep; 68(3):320-7. PubMed ID: 11014414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
    Liljequist S; Cebers G; Kalda A
    Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.
    Brambrink AM; Martin LJ; Hanley DF; Becker KJ; Koehler RC; Traystman RJ
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging.
    Jones N; O'Neill MJ; Tricklebank M; Libri V; Williams SC
    Psychopharmacology (Berl); 2005 Aug; 180(4):743-51. PubMed ID: 15864556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complestatin is a noncompetitive peptide antagonist of N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid/kainate receptors: secure blockade of ischemic neuronal death.
    Seo SY; Yun BS; Ryoo IJ; Choi JS; Joo CK; Chang SY; Chung JM; Oh S; Gwag BJ; Yoo ID
    J Pharmacol Exp Ther; 2001 Oct; 299(1):377-84. PubMed ID: 11561102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fructose-1,6-diphosphate, when given five minutes after injury, does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig.
    LeBlanc MH; Farias LA; Markov AK; Evans OB; Smith B; Smith EE; Brown EG
    Biol Neonate; 1991; 59(2):98-108. PubMed ID: 2036474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of LY293558, an AMPA receptor antagonist, on acute and chronic morphine dependence.
    McLemore GL; Kest B; Inturrisi CE
    Brain Res; 1997 Dec; 778(1):120-6. PubMed ID: 9462883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fructose-1,6-bisphosphate does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig.
    LeBlanc MH; Parker CC; Vig V; Smith EE; Brown EG
    Crit Care Med; 1992 Sep; 20(9):1309-14. PubMed ID: 1521447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
    O'neill MF; Sanger G; Ornstein PL; Osborne DJ; Woodhouse SM
    Psychopharmacology (Berl); 2005 Apr; 179(1):181-8. PubMed ID: 15821949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The GluK1 (GluR5) Kainate/{alpha}-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist LY293558 reduces soman-induced seizures and neuropathology.
    Figueiredo TH; Qashu F; Apland JP; Aroniadou-Anderjaska V; Souza AP; Braga MF
    J Pharmacol Exp Ther; 2011 Feb; 336(2):303-12. PubMed ID: 20962029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties.
    Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA
    J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation of in vivo effects of AMPA and NMDA receptor ligands using drug discrimination methods and convulsant/anticonvulsant activity.
    Arnt J; Sánchez C; Lenz SM; Madsen U; Krogsgaard-Larsen P
    Eur J Pharmacol; 1995 Oct; 285(3):289-97. PubMed ID: 8575516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitution.
    Ornstein PL; Arnold MB; Allen NK; Bleisch T; Borromeo PS; Lugar CW; Leander JD; Lodge D; Schoepp DD
    J Med Chem; 1996 May; 39(11):2219-31. PubMed ID: 8667365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonist.
    Ornstein PL; Arnold MB; Allen NK; Leander JD; Tizzano JP; Lodge D; Schoepp DD
    J Med Chem; 1995 Dec; 38(25):4885-90. PubMed ID: 8523401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of a GluR6 kainate receptor in cultured hippocampal neurons.
    Bleakman D; Ogden AM; Ornstein PL; Hoo K
    Eur J Pharmacol; 1999 Aug; 378(3):331-7. PubMed ID: 10493110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity.
    Puel JL; Pujol R; Tribillac F; Ladrech S; Eybalin M
    J Comp Neurol; 1994 Mar; 341(2):241-56. PubMed ID: 7512999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decahydroisoquinolines: novel competitive AMPA/kainate antagonists with neuroprotective effects in global cerebral ischaemia.
    O'Neill MJ; Bond A; Ornstein PL; Ward MA; Hicks CA; Hoo K; Bleakman D; Lodge D
    Neuropharmacology; 1998; 37(10-11):1211-22. PubMed ID: 9849659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine.
    Carlezon WA; Rasmussen K; Nestler EJ
    Synapse; 1999 Mar; 31(4):256-62. PubMed ID: 10051106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of polyethylene glycol-bound superoxide dismutase, polyethylene glycol-bound catalase, and nimodipine to prevent hypoxic ischemic injury to the brain of newborn pigs.
    LeBlanc MH; Vig V; Randhawa T; Smith EE; Parker CC; Brown EG
    Crit Care Med; 1993 Feb; 21(2):252-9. PubMed ID: 8428478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.